Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center

Form 483FOIA Uncovered

Westerly, Rhode Island, United StatesFEI 3010167719Issued April 15, 2022

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3010167719.

Observations2

Issue DateApril 15, 2022

StatusNo Warning Letter

Related Inspections5

Establishment Details

Firm: Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center
Location: Westerly, Rhode Island, United States
FEI Number: 3010167719
Product Type: Biologics
Issue Date: April 15, 2022
Country: United States

Inspection History, 2013 to 2022

NAI2

VAI3

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center FDA Form 483, Westerly, Rhode Island, April 15, 2022